DDX3X and Alzheimer disease: Similar to the effects of DDX3X cleavage, cleavage of amyloid-β precursor protein (APP) by AEP results in truncated APP (C586–689), which binds to CCAAT enhancer binding protein β (CEBPB), leading to its nuclear translocation and promoting AD progression (45).